Dioxin Conference
Skip to content

EHP

Research

Environ Health Perspect; DOI:10.1289/ehp.1206178

A Population-based Case–Control Study of Urinary Arsenic Species and Squamous Cell Carcinoma in New Hampshire, USA

Diane Gilbert-Diamond,1,2 Zhigang Li,1,2 Ann E. Perry,3 Steven K. Spencer,4 A. Jay Gandolfi,5 and Margaret R. Karagas1,2

Author Affiliations open
1Section of Biostatistics and Epidemiology, Department of Community and Family Medicine, 2Norris Cotton Cancer Center,;3Department of Pathology, and 4Department of Surgery, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA; 5Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, USA

PDF icon PDF Version (180 KB)

  • Background: Chronic high arsenic exposure is associated with squamous cell carcinoma (SCC) of the skin, and inorganic arsenic (iAs) metabolites may play an important role in this association. However, little is known about the carcinogenicity of arsenic at levels commonly observed in the United States.

    Objective: We estimated associations between total urinary arsenic and arsenic species and SCC in a U.S. population.

    Methods: We conducted a population-based case–control SCC study (470 cases, 447 controls) in a U.S. region with moderate arsenic exposure through private well water and diet. We measured urinary iAs, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA), and summed these arsenic species (ΣAs). Because seafood contains arsenolipids and arsenosugars that metabolize into DMA through alternate pathways, participants who reported seafood consumption within 2 days before urine collection were excluded from the analyses.

    Results: In adjusted logistic regression analyses (323 cases, 319 controls), the SCC odds ratio (OR) was 1.37 for each ln-transformed microgram per liter increase in ln-transformed ΣAs concentration [ln(ΣAs)] (95% CI: 1.04, 1.80). Urinary ln(MMA) and ln(DMA) also were positively associated with SCC (OR = 1.34; 95% CI: 1.04, 1.71 and OR = 1.34; 95% CI: 1.03, 1.74, respectively). A similar trend was observed for ln(iAs) (OR = 1.20; 95% CI: 0.97, 1.49). Percent iAs, MMA, and DMA were not associated with SCC.

    Conclusions: These results suggest that arsenic exposure at levels common in the United States relates to SCC and that arsenic metabolism ability does not modify the association.

  • Citation: Gilbert-Diamond D, Li Z, Perry AE, Spencer SK, Gandolfi AJ, Karagas MR. 2013. A population-based case–control study of urinary arsenic species and squamous cell carcinoma in New Hampshire, USA. Environ Health Perspect 121:1154–1160; http://dx.doi.org/10.1289/ehp.1206178

    Address correspondence to D. Gilbert-Diamond, Geisel School of Medicine at Dartmouth, Hinman Box 7937, One Medical Center Dr., Lebanon, NH 03756 USA. Telephone: (603) 653-3362. E-mail: Diane.Gilbert-Diamond@Dartmouth.edu

    We thank the many participants, physicians, and pathology laboratories comprising the New Hampshire Skin Cancer Study who contributed to making this study possible. We are also indebted to the study staff of the New Hampshire Skin Cancer Study and the New Hampshire Cancer Registry.

    This study was supported by grants R01 CA057494 and R25 CA134286 from the National Cancer Institute, National Institutes of Health (NIH), and grant P42 ES007373 from the National Institute of Environmental Health Sciences, NIH.

    The authors declare they have no actual or potential competing financial interests.

    Received: 24 October 2012
    Accepted: 16 July 2013
    Advance Publication: 19 July 2013
    Final Publication: 1 October 2013

  • PDF icon Supplemental Material (1.7 MB) PDF

Introduction

Nonmelanoma skin cancer is the most common type of malignancy among whites and has considerable related morbidity and health costs (Mudigonda et al. 2010). The incidence rates of both forms of nonmelanoma skin cancer—cutaneous squamous cell carcinoma (SCC) and basal cell carcinoma (BCC)—are dramatically increasing in the United States (Karagas et al. 1999; Rogers et al. 2010). Although BCC is more common, SCC has a greater tendency to metastasize and is responsible for greater mortality (Weinstock et al. 1991). Sunlight exposure, male sex, and older age are well known risk factors for SCC (Preston and Stern 1992).

Chronic exposure to arsenic (As) has been associated with SCC in regions of Taiwan where high exposures through drinking water were common (Tseng et al. 1968; Yeh et al. 1968); however, it is not clear whether lower levels of exposure that are common in the United States also are a risk factor for SCC. We previously reported increased odds of SCC in association with toenail As concentrations > 97th percentile [odds ratio (OR) = 2.07; 95% confidence interval (CI): 0.92, 4.66 compared with toenail As less than the median] in a case–control study in the U.S. state of New Hampshire (Karagas et al. 2001). Furthermore, we found evidence of a positive association with toenail As concentrations > 0.105 μg/g (Karagas et al. 2002), but not with concentrations below that value. Although toenail As concentration is considered a reliable long-term biomarker of As exposure (Garland et al. 1993), toenails primarily accumulate inorganic As (iAs), so our previous analysis could not examine specific As species that result from As metabolism.

Upon ingestion, iAs is methylated into monomethylarsonic acid (MMAV), which is then reduced to monomethylarsonous acid (MMAIII). In a second step, MMAIII is methylated to dimethylarsinic acic (DMAV), which is then reduced to dimethylarsinous acid (DMAIII) (Vahter 2002). This process is incomplete, such that iAs, MMAV, and DMAV are all present in the urine, the primary route of As excretion (Francesconi et al. 2002). Although MMAIII and DMAIII have been detected in the urine of people highly exposed to As (Mandal et al. 2001; Valenzuela et al. 2005), they have not been found in most studies of people exposed to lower levels of As (Lindberg et al. 2006; Rivera-Núñez et al. 2011).

Arsenic methylation was initially considered a detoxification process because MMAV and DMAV are considered less toxic than iAs and are easily excreted (Gebel 2002; Moore et al. 1997). However, growing evidence suggests that MMAIII and DMAIII are more toxic than their pentavalent forms and that they may even be more toxic than iAs (Mass et al. 2001; Petrick et al. 2000; Styblo et al. 2000). Given their differing toxicities, it is likely that various As species have different health effects. Studies of populations exposed to high levels of As suggest that the profile of urinary As species may affect As-related skin pathologies; for example, individuals who have lower concentrations of urinary MMA relative to DMA may be at lower risk of As-induced skin lesions (Kile et al. 2011; Yu et al. 2000), nonmelanoma skin cancers combined (Chen et al. 2003), and BCC (Leonardi et al. 2012). To our knowledge, no studies have specifically examined the association between As metabolites and skin cancer in a U.S. population, nor have any studies focused specifically on SCC. We therefore extended our population-based case–control study in New Hampshire to investigate the relation between individual urinary As species and the incidence of SCC.

Methods

In collaboration with > 90% of the dermatologists and pathologists practicing in New Hampshire and bordering areas, we identified incident cases of invasive SCC of the skin that were newly diagnosed in residents 25–74 years of age from July 2003 through June 2009. Study staff reviewed pathology log books and medical charts at participating dermatology and pathology clinics in order to identify all eligible SCC cases. We selected a control group of New Hampshire residents from the Center for Medicare and Medicaid services (for those ≥ 65 years of age) and driver’s license records provided by the New Hampshire Department of Transportation (for those < 65 years of age), frequency matched to cases on sex and age (25–35, 36–45, 46–50, 51–59, 60–64, 65–69, and 70–74 years) (Applebaum et al. 2007). To be eligible, cases and controls were required to be English-speaking, mentally competent residents of New Hampshire with a working telephone number. Cases and controls were still eligible to participate if they had a previous SCC that was diagnosed prior to the study period. The enrollment and interviews for cases and controls happened concurrently and at about the same rate over the course of the study. The present analysis includes cases and controls interviewed 1 July 2006–10 August 2011. Of 579 SCC cases confirmed eligible, we enlisted 510 (88%), and of the 594 controls, 483 participated (81%).

After study participants gave written informed consent, a study staff member who was blinded to their case/control status interviewed them in person to obtain sociodemographic, lifestyle, medical, and sun exposure information. Home tap water samples were collected from participants’ homes into a commercially washed (mineral-free) high-density polyethylene bottle that meets U.S. Environmental Protection Agency standards for water collection (I-Chem; Thermo Fisher Scientific, Waltham, MA) by study staff wearing individually packed, clean, powderless gloves and following a strict protocol to limit contamination (Karagas et al. 2001). A urine-collection kit with instructions and materials necessary to collect a first-morning-void urine sample was mailed to the participants. The kit included a prelabeled screw-top, 120 mL collection container containing 30 μL diammonium diethyldithiocarbamate to stabilize As species, an insulated thermos, and instructions to refrigerate the urine sample in the thermos until giving it to the interviewer later that day. In addition, participants were asked to complete a 3-day water, rice, and seafood intake record for the 3 days immediately before urine collection. All procedures and study materials were approved by the Committee for the Protection of Human Subjects at Dartmouth College.

Water As analysis. Tap water samples were tested at the Trace Element Analysis Core at Dartmouth using inductively coupled plasma mass spectrometry (ICP-MS) with a quadrupole collision cell 7500c Octopole Reaction System ICP mass spectrometer (Agilent) and helium as a collision gas to remove polyatomic interferences, as described previously by Karagas et al. (2001). The limit of detection (LOD) of these analyses ranged from 0.002 μg/L to 0.075 μg/L, with detectable levels in > 96.7% of the samples. When water As measurements were not available, we set the water As concentration to one-half the LOD. The average coefficient of variation for these analyses was 3.22%.

Urinary analysis. Urine samples from cases and controls were frozen at –80°C within 24 hr of collection and shipped on dry ice to the University of Arizona, where they were analyzed using a high-performance liquid chromatography (HPLC) ICP-MS system and previously described methods (Gilbert-Diamond et al. 2011). This As speciation method quantifies the concentration of iAs species (iAsIII and iAsV) and organic As species (MMAV, DMAV, and arsenobetaine (AsB). No cases or controls had concentrations below the DMA LOD (0.11 μg/L); 3.6% of cases and 4.5% of controls were below the MMA LOD (0.14 μg/L); 32.3% of cases and 31.8% of controls were below the iAsIII LOD (0.15 μg/L); and 82.1% of cases and 87.5% of controls were below the iAsV LOD (0.10 μg/L). Urinary As concentrations < LOD were set to one-half LOD.

We calculated the sum of urinary iAs and methylated As species (ΣAs) by summing concentrations of iAs, MMA, and DMA. AsB was excluded from this analysis because it is thought to pass through the body without being metabolized and is nontoxic (Francesconi et al. 2002). The percentage of each As species (%iAs, %MMA, %DMA) in urine samples was calculated by dividing the concentration of each species by the concentration of ΣAs. We calculated the ratio of urinary MMA to iAs as a biomarker of the primary methylation capability, and the ratio of urinary DMA to MMA as a biomarker of the secondary methylation capability (Chen et al. 2003). Urinary creatinine was measured with a colorimetric assay (Assay #500701; Cayman Chemical, Ann Arbor, MI).

Data analysis. We first evaluated the association between individual urinary As species and factors that could potentially influence urinary As concentrations in bivariate regression models among controls (n = 447). Urinary As concentrations were natural log (ln)-transformed to improve normality. Self-reported rice consumption, including cooked rice and rice cereals, was converted into equivalents of cooked rice using previously described methods (Gilbert-Diamond et al. 2011). To focus on iAs and its methylation products, we excluded the 275 participants who reported eating seafood in the 2 days before sample collection. We chose a 2-day window based on As excretion dynamics (Buchet et al. 1981), although results were consistent in a sensitivity analysis that used a 3-day window to define nonseafood consumers (data not shown). We then fit individual generalized linear models with a logit transform to estimate ORs for SCC in association with a unit increase in urinary ΣAs, iAs, MMA, DMA, %iAs, %MMA, %DMA, iAs/MMA, and DMA/MMA. To improve normality of urinary As species and reduce the influence of potential outliers, we also fit models with ln-transformed urinary As [ln(As)]. We also estimated ORs for SCC according to tertiles of urinary As concentrations (based on the distribution in the controls) to explore possible nonlinear associations. All models were fit with and without adjustment for sex, age (continuous), body mass index (BMI; continuous), education (high school, college, or graduate school), smoking status (at time of diagnosis/reference age: never, former, current), skin reaction to chronic sun exposure (very tan, moderately tan, mildly tan, or freckle/no tan), and urinary creatinine concentration—a measure of urinary dilution (continuous). Resources were available to measure urinary creatinine only in a subset of samples (n = 596), so we used multiple imputation and fully conditional specification methods to account for missing data (van Buuren 2007). Models for As percentages and ratios were also adjusted for water As concentration to control for potential confounding by iAs exposure. We performed a sensitivity analysis in which we restricted analyses to non–rice eaters because rice is known to contain DMA (Williams et al. 2005). To account for DMA introduced by unreported fish consumption, we also did a sensitivity analysis in which we further adjusted for urinary AsB. To explore whether the association between urinary As and SCC varied by duration of current water supply use, we stratified participants according to the median duration of current water supply use (< 17 years or ≥ 17 years) and estimated ORs for SCC using covariate-adjusted logistic regression models with ln-transformed urinary As as the exposure. All regression analyses were performed with SAS, version 9.2 (SAS Institute Inc., Cary, NC).

We used a structural equation model to simultaneously model associations between SCC and urinary As metabolites (iAs, MMA, and DMA), water As concentration, and rice consumption. The three urinary As variables are highly correlated and thus ill-suited to be included in a single logistic regression model. The structural equation model permits iAs, MMA, and DMA to each load differently onto a single latent urinary As variable (UAM) based on their correlation structure; the loading score of each As species indicates its relative contribution to the variable. Robust weighted least-square estimators were used to estimate parameters in the model. We used the comparative fit index (Bentler 1990) and Tucker–Lewis index (Tucker and Lewis 1973) to evaluate the model fit. We calculated the indirect association between water As and SCC and rice consumption and SCC, through the latent UAM variable, and tested its statistical significance using the Sobel Z test (Shrout and Bolger 2002). For the purpose of comparison, we also created a UAM model without the assumption of unobserved variables by replacing the latent UAM variable with the simple sum of the three urinary As metabolites in the model. The type I error rate used to define statistical significance is 0.05 for these models. The structural equation model analysis was conducted using Mplus, version 6.12 (Muthén & Muthén, Los Angeles, CA).

Results

The mean (± SD) time between SCC diagnosis and interview/urine collection was 23 ± 10.2 months. Urine samples were collected from 470 SCC cases (92%) and 447 controls (75%), resulting in a total sample size of 917. The sex and age distributions and the percentage of urban versus rural residence did not differ for eligible cases and those who participated in our study. The sex distribution and percentage of urban versus rural residence also did not differ between identified controls and those who participated in our study; however, controls who did participate tended to be older (63 years vs. 56 years). In cases interviewed for our study, 98.5% of those 25–64 years of age had a valid driver’s license at the time of interview, and 98% of those 65–74 years of age were enrolled in Medicare, thus indicating that most would have been included in the data sources used to identify controls. The sex and age group distributions for SCC cases and controls were similar, and approximately 99% of all participants reported their race as white (Table 1). In addition, urban versus rural residence as well as the type of household water supply and length of use were similar between cases and controls, with 58% of cases and 54% of controls consuming water from a shared or private well and an overall median water supply usage of 17 and 18 years, respectively. The consumption of fish and rice in the 2 days immediately before urine collection was also similar in cases and controls. Compared with controls, cases generally had an increased sun sensitivity, measured as a lower tendency to tan with chronic sun exposure (Table 1). On average, cases also had a lower BMI, higher level of education, and lower likelihood to have ever smoked compared with controls.

ehp.1206178.t001Table 1 - Selected characteristics of squamous cell carcinoma (SCC) cases and controls [n (%) or median (IQR)].

View Table (HTML Version)
View larger image (TIF File)

Median urinary ΣAs, iAs, MMA, and DMA concentrations were higher in cases than controls (Table 1). In bivariate analyses restricted to controls, age, BMI, and water As concentration were associated with ln-transformed concentrations of urinary ΣAs, iAs, MMA, and DMA (see Supplemental Material, Table S1). In addition, male sex was associated with higher urinary ln(iAs) and ln(MMA), and a higher education level was associated with higher urinary ln(ΣAs), ln(iAs), and ln(DMA). Seafood consumption was associated with higher urinary ΣAs, largely because of higher urinary DMA; each 4-oz. serving of seafood was associated with an estimated 53% (95% CI: 37%, 71%) increase in urinary DMA concentration.

Among participants who reported not eating seafood in the 2 days prior to urine collection (323 cases, 319 controls), we observed a linear association between SCC and ΣAs, MMA, and DMA (Table 2). After adjustment for sex, age, BMI, education, smoking status, skin reaction to chronic sun exposure, and urinary creatinine the OR of SCC was 1.33 for each 1-μg/L increase in urinary MMA (95% CI: 1.04, 1.70) (Table 2). Urinary ΣAs and DMA were also associated with increased odds of SCC. Positive associations with SCC were also observed after ln-transforming the urinary As variables. The OR for each ln-transformed microgram per liter increase of ln(ΣAs) was 1.37 (95% CI: 1.04, 1.80). The ORs for each 1-ln(μg/L) increase in ln(MMA) and ln(DMA) were 1.34 (95% CI: 1.04, 1.71) and 1.34 (95% CI: 1.03, 1.74), respectively. In contrast, SCC was not associated with the percentage of urinary As species or As methylation ratios (see Supplemental Material, Table S2). Results were not sensitive to creatinine adjustment (data not shown). In addition, results were not substantially different when using a 3-day window to define seafood consumers, nor after further adjustment for urinary AsB (data not shown). Regression coefficients were similar in unadjusted and adjusted models after excluding an additional 65 cases and 59 controls who reported eating rice in the previous 2 days, although the smaller sample size resulted in slightly wider confidence intervals (see Supplemental Material, Table S3).

ehp.1206178.t002Table 2 - Unadjusted and adjusted ORs (95% CIs) of squamous cell carcinoma (SCC) by urinary As concentration units or tertiles among cases and controls who did not report seafood consumption for the 2 days prior to urine sample collection (323 cases, 319 controls).

View Table (HTML Version)
View larger image (TIF File)

Urinary MMA concentration was significantly associated with odds of SCC when urinary As was examined by tertiles of exposure (Table 2). Participants in tertile 3 of urinary MMA had 76% higher odds of SCC than those in tertile 1 (OR = 1.76, 95% CI: 1.09, 2.84). Participants in tertile 3 of urinary ΣAs, iAs, and DMA also had increased odds of SCC, although none of the ORs reached statistical significance.

In an analysis stratified by the median duration of current water supply usage, ORs for SCC were positively associated with unit increases in ln-transformed urinary As species in both strata (< 17 years and ≥ 17 years) (Table 3). ORs were somewhat larger among those with a shorter duration of current water usage, but the differences in the slopes between the two strata were not statistically significant.

ehp.1206178.t003Table 3 - Adjusted ORs (95% CIs) of squamous cell carcinoma (SCC) by ln‑transformed urinary As concentration among participants who did not report seafood consumption for the 2 days prior to urine sample (323 cases, 319 controls), with data stratified at the sample median of current water supply use duration.

View Table (HTML Version)
View larger image (TIF File)

In a structural equation model adjusted for the same set of covariates, iAs, MMA, and DMA each contributed significantly to the latent UAM variable (loading scores = 0.80, 0.52, and 0.49, respectively) (see Supplemental Material, Figure S1). The comparative fit index (> 0.90) and the Tucker Lewis Index (> 0.90) indicated a reasonable model fit. We found an association between the latent UAM variable and SCC [OR per 1-SD increase = 2.04 (95% CI: 1.35, 3.10)]. Water As concentration was associated with the latent UAM variable [1-SD increase in UAM for each 10-μg/L increase in water As = 0.32 (95% CI: 0.30, 0.34)]; the indirect association between water As concentration and SCC through UAM was also significant [for every 1-μg/L increase in water As, OR = 1.02 (95% CI: 1.01, 1.04)]. The structural equation model that did not assume unobserved variables (see Supplemental Material, Figure S2) also showed a significant, but weaker, association between ΣAs and SCC [for each 1-unit increase of ΣAs, OR = 1.02 (95% CI: 1.00, 1.03)].

Discussion

In this U.S. population–based case–control study of participants living in a region with detectable As in drinking water, we estimated positive associations between SCC and urinary ΣAs, MMA, and DMA concentrations. The results of our structural equation model analysis suggest that a latent urinary As variable representing urinary iAs, MMA, and DMA is associated with SCC. In contrast, percentages and ratios of the individual metabolites were not associated with SCC in the study population.

In our analysis, we were interested in ingested iAs and the products of its methylation: MMA and DMA. In our population, where water As concentrations are relatively low, dietary sources of iAs can play a more substantial role in overall As exposure (European Food Safety Authority 2009). For example, previous studies have found rice consumption to be a significant predictor of urinary iAs (Cascio et al. 2011; Gilbert-Diamond et al. 2011). In our adult study population, however, the prevalence of rice consumption was only 22% in the 2 days immediately before urine collection and was not significantly associated with urinary iAs (see Supplemental Material, Table S1). Seafood is the main dietary source of organic As compounds, including AsB, arsenolipids, and arsenosugars, and the latter two compounds are metabolized into DMA (Cullen and Reimer 1989; Francesconi 2010). Other studies have reported seafood consumption as a major predictor of urinary DMA in U.S. populations (Navas-Acien et al. 2011; Rivera-Núñez et al. 2012), as we observed in our study population (see Supplemental Material, Table S1). Given the different biotransformation pathways of iAS and organic As compounds that result in DMA, as well as their potential differing toxicity (Cullen and Reimer 1989), we excluded participants who reported seafood consumption for the 2 days prior to urine collection. Although rice consumption was a significant predictor of urinary DMA in our study (see Supplemental Material, Table S1), we chose not to exclude rice consumers from our analysis because we were interested in all potential sources of ingested iAs. However, results of sensitivity analyses that excluded rice consumers were generally consistent with the main analyses (see Supplemental Material, Table S3).

Previous ecological studies in the As endemic region of southwest Taiwan (Tseng et al. 1968; Yeh et al. 1968) support an association between high levels of As exposure through well water and SCC. Consistent with our previous work using toenail As as a biomarker (Karagas et al. 2001), results from the present study of urinary As suggest that the association between As and SCC extends to lower levels of As exposure. To our knowledge, no other studies have examined urinary As species and SCC in populations with similar levels of As exposure for direct comparison. Studies in more highly exposed populations have examined urinary As species and As-induced skin pathologies. For example, the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh reported that total urinary As was associated with the risk of incident skin lesions [including melanosis and keratosis, known precursors to skin cancer (Sober and Burstein 1995; Woolgar and Triantafyllou 2011)] in a cohort of 10,182 adults (Argos et al. 2011). In a cross-sectional study of 76 residents of an As endemic region of Mexico with drinking water As concentrations ≥ 50 μg/L, urinary MMAIII was significantly higher among those with As-related skin lesions (n = 55) compared with those without (n = 21); however, there was no difference in concentrations of MMAV, DMAIII, DMAV, iAsIII, iAsV, or the sum of iAs and methylated As species (Valenzuela et al. 2005). The percentage or ratio of urinary As metabolites is thought to reflect individual differences in the ability to metabolize iAs, and there is some evidence that they reflect increased susceptibility to As-induced skin lesions. For example, in a case–control study (n = 76 cases, 224 controls) in southwest Taiwan, Chen et al. (2003) reported that a low urinary DMA:MMA ratio was positively associated with skin cancer (BCC or SCC) in participants with high lifetime exposure to As (> 15 mg/L per year). In another smaller Taiwanese case–control study (n = 26 cases, 26 controls), Yu et al. (2000) reported that individuals with > 15.5% MMA had significantly higher odds of skin disorders (including BCC, SCC, and hyperkeratosis/hyperpigmentation) than did those with ≤ 15.5% MMA (OR = 5.5). In 594 cases and 1,041 controls in the HEALS study, urinary %MMA and the DMA:MMA ratio were significantly associated with skin lesions (including keratosis and melanosis) (Ahsan et al. 2007); the top quartile of %MMA (median, 20.2%) was associated with increased odds of skin lesions compared with the lowest quartile (median, 7.5%) [OR = 1.57 (95% CI: 1.10, 2.26)], and the top quartile of DMA:MMA (median, 10.9) was associated with reduced odds of skin lesions compared with the lowest quartile (median, 3.1) [OR = 0.64 (95% CI: 0.44, 0.91)]. In another large Bangladeshi case–control study of skin lesions (including SCC as well as keratosis and melanosis; n = 859 cases, 868 controls), Kile et al. (2011) reported an OR of 1.56 (95% CI: 1.15, 2.12) associated with each increase in log10 percentage of MMA. At the relatively low levels of As exposure in our population in the present study, SCC was associated with the absolute concentrations of MMA and DMA measured in urine but not the relative proportions of MMA, DMA, and iAs. Thus, it is not clear whether differences in the proportion of As metabolites reflect susceptibility to skin cancers at lower levels of exposure.

The observed association between methylated forms of As and SCC may reflect the carcinogenicity of those methylated forms or their chemical predecessors. iAs is known to be carcinogenic, although the biological mechanisms are not yet fully understood (International Agency for Research on Cancer 2004). In experimental systems, iAs exposure leads to increased generation of reactive oxygen species (ROS), which in turn lead to DNA damage and increased oxidative sensitive gene expression (Shi et al. 2004). For example, in a recent in vitro study in human immortalized lung epithelial cells and adenocarcinoma cells, Liu et al. (2011) reported that As-induced ROS generation activated protein kinase AKT and the extracellular signal-regulated kinase (ERK1/2) leading to increased downstream expression of vascular endothelial growth factor (VEGF), an important angiogenesis regulator. iAs may be carcinogenic through promotion of mitochondrial activity, a process that could fuel the increased energy demands of quickly replicating cells, as well as lead to increased ROS generation (Lee et al. 2011). Arsenic exposure may also promote carcinogenesis through altering the methylation of oncogenes and tumor suppressor genes (reviewed by Cheng et al. 2012). This altered DNA methylation may result from a depletion of cellular S-adenosylmethionine (Coppin et al. 2008; Reichard and Schnekenburger 2007; Zhao et al. 1997), an essential methyl donor, by the As methylation pathway. It is still unclear whether iAs methylation products are equally—or even more—carcinogenic compared with iAs. In an in vitro study of human epidermal keratinocytes, Vega et al. (2001) showed that trivalent and pentavalent MMA and DMA affected cellular viability, proliferation, and cytokine excretion to approximately the same extent as their inorganic counterparts. Another study of human keratinocytes showed evidence that MMAIII may be even more cytotoxic than iAsIII (Styblo et al. 2000). There is also in vitro evidence of greater genotoxicity of MMAIII (Mass et al. 2001; Schwerdtle et al. 2003) and DMAIII (Schwerdtle et al. 2003) compared with iAsIII and that the genotoxicity is mediated by ROS (Nesnow et al. 2002). Further work is necessary to clarify the biological mechanisms of As carcinogenicity and to understand the relative carcinogenicity of iAs and its metabolites in the in vivo context.

In the present study we were unable to measure urinary As prior to SCC diagnosis. Therefore, we cannot exclude the possibility that cases could have changed some behaviors related to As exposure after their diagnosis and before urine collection. In addition, it is possible that SCC treatment could have resulted in changes in As excretion; however, this is unlikely because the primary treatment for SCC is surgical removal of the carcinoma. Prospective studies are needed to better understand the temporality of the observed association. Prospective studies can also elucidate the latency period of low-dose As exposure and associated SCC, which is currently unknown.

Another limitation of our study is that we have a single urinary As measurement, which may not adequately reflect long-term exposure. In a U.S. study of Native American populations (n = 60), Navas-Acien (2009) found that urinary As excretion (including As concentrations and percent of urinary As species) remained fairly constant over a 10-year period. In a study in Bangladesh that measured urinary As in 196 participants over 2 years, Kile et al. (2009) also found that the concentrations of urinary As species were fairly reproducible over time, but the percent of As species varied. Studies from Chile (n = 73) (Hopenhayn-Rich et al. 1996) and the United States (n = 81) (Steinmaus et al. 2005) reported that proportions of As species were fairly stable over time, but only over 2 months and 1 year, respectively. Overall, findings from previous studies suggest that a single urinary measurement may be a reliable measure of exposure for a period of months to years. We recognize, however, that the latency period for As exposure could be very long. Our participants tended to use the same water source for many years (median, 17 years); although water As concentration was associated with urinary As (see Supplemental Material, Table S1), other factors such as diet also influence As exposure (European Food Safety Authority 2009). ORs stratified by the duration of current water system use did not significantly differ (Table 3). Our study was also limited by the fact that we were unable to measure As concentrations directly in the tissue of interest, the skin. Further understanding about As metabolism, tissue distribution, and excretion is necessary to understand the biological interpretation of the associations between urinary As and SCC in our study population.

Conclusion

Using sensitive methods to measure urinary As exposure in a population-based study of SCC in residents of New Hampshire, we observed that urinary concentrations of ΣAs, MMA, and DMA were positively associated with SCC. These findings suggest that common exposure levels may influence cancer risk in the United States and elsewhere.

Correction

In Table 1 of the manuscript originally published online, the numbers of SCC cases under “highest level of education” were incorrect. In addition, for seafood and rice consumption, the values for cases and controls were switched, and the numbers for “missing” were accidentally included in the “no” totals. The errors have been corrected here.


References

Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, Jasmine F, et al. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol Biomarkers Prev 16:1270–1278.

Applebaum KM, Karagas MR, Hunter DJ, Catalano PJ, Byler SH, Morris S, et al. 2007. Polymorphisms in nucleotide excision repair genes, arsenic exposure, and non-melanoma skin cancer in New Hampshire. Environ Health Perspect 115:1231–1236; doi:10.1289/ehp.10096.

Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T, et al. 2011. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol 174:185–194.

Bentler PM. 1990. Comparative fit indexes in structural models. Psychol Bull 107:238–246.

Buchet JP, Lauwerys R, Roels H. 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48:71–79.

Cascio C, Raab A, Jenkins RO, Feldmann J, Meharg AA, Haris PI. 2011. The impact of a rice based diet on urinary arsenic. J Environ Monit 13:257–265.

Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, Ryan LM, et al. 2003. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45:241–248.

Cheng T, Choudhuri S, Muldoon-Jacobs K. 2012. Epigenetic targets of some toxicologically relevant metals: a review of the literature. J Appl Toxicol 32:643–653.

Coppin JF, Qu W, Waalkes MP. 2008. Interplay between cellular methyl metabolism and adaptive efflux during oncogenic transformation from chronic arsenic exposure in human cells. J Biol Chem 283:19342–19350.

Cullen WR, Reimer KJ. 1989. Arsenic speciation in the environment. Chem Rev 89:713–764.

European Food Safety Authority. 2009. EFSA J. Scientific opinion on arsenic in food. Available: http://www.efsa.europa.eu/en/efsajournal​/doc/1351.pdf [accessed 19 August 2013].

Francesconi KA. 2010. Arsenic species in seafood: origin and human health implications. Pure Appl Chem 82:373–381.

Francesconi KA, Tanggaar R, McKenzie CJ, Goessler W. 2002. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin Chem 48:92–101.

Garland M, Morris JS, Rosner BA, Stampfer MJ, Spate VL, Baskett CJ, et al. 1993. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493–497.

Gebel TW. 2002. Arsenic methylation is a process of detoxification through accelerated excretion. Int J Hyg Environ Health 205:505–508.

Gilbert-Diamond D, Cottingham KL, Gruber JF, Punshon T, Sayarath V, Gandolfi AJ, et al. 2011. Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci USA 108:20656–20660.

Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH. 1996. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect 104:1200–1207.

International Agency for Research on Cancer. 2004. Some Drinking-Water Disinfectants and Contaminants, including Arsenic. IARC Monogr Eval Carcinog Risks Hum 84:1–477. Available: http://monographs.iarc.fr/ENG/Monographs​/vol84/mono84.pdf [accessed 16 August 2013].

Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA. 1999. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer 81:555–559.

Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK, et al. 2001. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 153:559–565.

Karagas MR, Stukel TA, Tosteson TD. 2002. Assessment of cancer risk and environmental levels of arsenic in New Hampshire. Int J Hyg Environ Health 205:85–94.

Kile ML, Hoffman E, Hsueh YM, Afroz S, Quamruzzaman Q, Rahman M, et al. 2009. Variability in biomarkers of arsenic exposure and metabolism in adults over time. Environ Health Perspect 117:455–460; doi:10.1289/ehp.11251.

Kile ML, Hoffman E, Rodrigues EG, Breton CV, Quamruzzaman Q, Rahman M, et al. 2011. A pathway-based analysis of urinary arsenic metabolites and skin lesions. Am J Epidemiol 173:778–786.

Lee CH, Wu SB, Hong CH, Liao WT, Wu CY, Chen GS, et al. 2011. Aberrant cell proliferation by enhanced mitochondrial biogenesis via MTTFA in arsenical skin cancers. Am J Pathol 178:2066–2076.

Leonardi G, Vahter M, Clemens F, Goessler W, Gurzau E, Hemminki K, et al. 2012. Arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case–control study. Environ Health Perspect 120:721–726; doi:10.1289/ehp.1103534.

Lindberg AL, Goessler W, Gurzau E, Koppova K, Rudnai P, Kumar R, et al. 2006. Arsenic exposure in Hungary, Romania and Slovakia. J Environ Monit 8:203–208.

Liu LZ, Jiang Y, Carpenter RL, Jing Y, Peiper SC, Jiang BH. 2011. Role and mechanism of arsenic in regulating angiogenesis. PLoS One 6:e20858; doi:10.1371/journal.pone.0020858.

Mandal BK, Ogra Y, Suzuki KT. 2001. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem Res Toxicol 14:371–378.

Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, Thomas J, et al. 2001. Methylated trivalent arsenic species are genotoxic. Chem Res Toxicol 14:355–361.

Moore MM, Harrington-Brock K, Doerr CL. 1997. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat Res 386:279–290.

Mudigonda T, Pearce DJ, Yentzer BA, Williford P, Feldman SR. 2010. The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 8:888–896.

Navas-Acien A, Francesconi KA, Silbergeld EK, Guallar E. 2011. Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ Res 111:110–118.

Navas-Acien A, Umans JG, Howard BV, Goessler W, Francesconi KA, Crainiceanu CM, et al. 2009. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the Strong Heart Study. Environ Health Perspect 117:1428–1433; doi: .10.1289/ehp.0800509.

Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR, et al. 2002. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 15:1627–1634.

Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H. 2000. Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes. Toxicol Appl Pharmacol 163:203–207.

Preston DS, Stern RS. 1992. Nonmelanoma cancers of the skin. N Engl J Med 327:1649–1662.

Reichard JF, Schnekenburger M, Puga A. 2007. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem Biophys Res Commun 352:188–192.

Rivera-Núñez Z, Linder MA, Chen B, Nriagu JO. 2011. Low-level determination of six arsenic species in urine by high performance liquid chromatography-inductively coupled plasma-mass spectrometry (HPLC-ICP-MS). Anal Methods 3:1122–1129.

Rivera-Núñez Z, Meliker JR, Meeker JD, Slotnick MJ, Nriagu JO. 2012. Urinary arsenic species, toenail arsenic, and arsenic intake estimates in a Michigan population with low levels of arsenic in drinking water. J Expo Sci Environ Epidemiol 22:182–190.

Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. 2010. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146:283–287.

Schwerdtle T, Walter I, Mackiw I, Hartwig A. 2003. Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24:967–974.

Shi H, Shi X, Liu KJ. 2004. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol Cell Biochem 255:67–78.

Shrout PE, Bolger N. 2002. Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 7:422–445.

Sober AJ, Burstein JM. 1995. Precursors to skin cancer. Cancer 75:645–650.

Steinmaus C, Yuan Y, Kalman D, Atallah R, Smith AH. 2005. Intraindividual variability in arsenic methylation in a US population. Cancer Epidemiol Biomarkers Prev 14:919–924.

Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, et al. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289–299.

Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh S. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453–463.

Tucker L, Lewis C. 1973. The reliability coefficient for maximum likelihood factor analysis. Psychometrika 38:1–10.

Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181–182:211–217.

Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, Calderon-Aranda ES, et al. 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ Health Perspect 113:250–254; doi:10.1289/ehp.7519.

van Buuren S. 2007. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:219–242.

Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D. 2001. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol Appl Pharmacol 172:225–232.

Weinstock MA, Bogaars HA, Ashley M, Litle V, Bilodeau E, Kimmel S. 1991. Nonmelanoma skin cancer mortality. A population-based study. Arch Dermatol 127:1194–1197.

Williams PN, Price AH, Raab A, Hossain SA, Feldmann J, Meharg AA. 2005. Variation in arsenic speciation and concentration in paddy rice related to dietary exposure. Environ Sci Technol 39:5531–5540.

Woolgar JA, Triantafyllou A. 2011. Squamous cell carcinoma and precursor lesions: clinical pathology. Periodontol 2000 57:51–72.

Yeh S, How SW, Lin CS. 1968. Arsenical cancer of skin. Histologic study with special reference to Bowen’s disease. Cancer 21:312–339.

Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9:1259–1262.

Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. 1997. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 94:10907–10912.


WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien